Archives: Agenda

Clinical R&D outsourcing needs and models have evolved over the last few years. Many biopharma companies are transitioning to a function-driven sourcing model where we can have a set of fit-for-purpose preferred suppliers to bring in flexibility and agility. Challenges in sourcing needs, pros and cons of different sourcing models will be discussed.

• Addressing historical issues with trial recruitment in certain populations in order to ensure diversity
• Community outreach as a method to reduce distrust around clinical trial participation
• Sourcing new sites in communities with high numbers of under-represented populations
• Language and translation: how to ensure your trial materials are accessible to non English speaking participants

• The evolution of CRO-sponsor collaboration into a more strategic, outcomes-driven partnership.
• Improving delivery, alignment, and trust in clinical development
• Mapping a draft development pathway with the end in mind

• KPIs in clinical research: what should you be measuring to determine your performance?
• Working collaboratively with your CROs and vendors throughout your clinical trial: where are you falling short?
• Tools and technology available to facilitate processes around performance measurement

• Priorities and considerations when working with vendors and external suppliers
• Cultivating collaborative relationships with vendors and CROs
• Managing procurement and outsourcing during an integration of two companies
• Developing a plan for effective supplier relationship management to ensure your trial runs smoothly

MODERATOR:
John Seman, Chief Executive Officer, Revitale Pharma

PANELLISTS:
Albert A Siha, Group Lead Director, Oncology, Internal Medicine, and Inflammation & Immunology, Pfizer Nupur Modi Murali, Director, Clinical Operations, Bausch Health Kathleen Cohen, Senior Vice President, Clinical Development Operations, Avalo Therapeutics Susan Neal, Senior Director, Clinical Operations, Novavax

• Healthcare themes in a Trump Administration
• Update on key priorities and opportunities
• Short and long term effects of staffing and budget cuts

Most central labs are built to process samples. Ours was built to understand them. Evolving from a world-class bioanalytical backbone, Frontage Central Lab brings scientific depth, quality rigor, and operational discipline to every protocol, amendment, and shipment. This talk unpacks how our BioA heritage uniquely equips us to manage complex sample logistics, adapt to protocol deviations, and align with today’s complex and evolving clinical trials!

• Ensuring your trial is cost-conscious and efficient without compromising on quality or on patient care
• Forecasting and budgeting in order to accurately predict costs and minimize unforeseen expenses
• Keeping your clinical budget on track
• Negotiating prices and contracts in order to ensure maximum benefit without going over budget